Valentin Fuster, M.D., Ph.D.
Director, Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, New York , USA
General Director of the National Center for Cardiovascular Research (CNIC), Madrid, Spain
Editor-in-Chief of the Journal of the American College of Cardiology
The United States of America
Professor Dr. Valentin Fuster received his Doctor of Medicine from University
of Barcelona, Spain, and Doctor of Philosophy from the University of Edinburgh,
the United Kingdom.
Ever since 1970, Professor Fuster has persevered in studying the roles of platelets that account for coronary artery occlusion and the benefit of antiplatelet drugs in preventing the occlusion of the bypassed vessels after coronary artery bypass graft (CABG) operation. The experiment was initiated in laboratory animals before subsequent definitive trial in humans. He was the first authority who demonstrated the effectiveness of antiplatelet agent in the prevention of the occlusion of the bypassed vessels after bypass operation. The explicit knowledge from his studies leads to the development of drug-eluting coronary stent that has been widely used to treat the patients with myocardial infarction requiring the dilation of coronary artery by balloon angioplasty and stent placement. Professor Fuster’s research works not only have saved many lives of coronary artery disease patients but also preferably refine the management of this disease nowadays.
The achievement of Professor Dr.Valentin Fuster is the result of bridging and magnifying the basic research knowledge into the novel insights that are beneficial to many patients especially the introduction of antiplatelet therapy. His exceptional works have saved millions of lives around the world.